Fiona Marshall: We’re entering a strategic research collaboration with Isomorphic Labs

Fiona Hamilton Marshall, President of the Novartis Institute for BioMedical Research, shared on X/Twitter:

“I’m excited to share that we’re entering a strategic research collaboration with Isomorphic Labs to use state-of-the-art AI technologies—including the next-gen model of AlphaFold—to discover novel small molecule therapeutics for select biological targets.”

Source: Fiona Marshall/X